MedTrace Logo

Communities Fighting COVID-19!

NCT05148936 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32750

Last updated 2024-06-14

No results posted yet for this study

Summary

To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.

Conditions

  • Covid19

Interventions

OTHER

COVID-19 Testing Home-based (Aim 1)

Implementation of Antigen and PCR testing at participant homes

OTHER

COVID-19 Testing Mobile (Aim 1)

Implementation of Antigen and PCR testing at mobile test sites

OTHER

COVID-19 Testing Mobile Approach 1 (Aim 2)

Implementation of Antigen and PCR testing at mobile test sites - active outreach

OTHER

COVID-19 Testing Mobile Approach 2 (Aim 2)

Implementation of Antigen and PCR testing at mobile test sites - baseline outreach

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • San Diego State University

    lead OTHER

Principal Investigators

  • Susan M Kiene, PhD · San Diego State University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-25
Primary Completion
2023-08-25
Completion
2023-08-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05148936 on ClinicalTrials.gov